NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pain Relief | ACETAMINOPHEN | Demoulas Super Markets, Inc | 39800c27-f39f-cd60-e063-6394a90acd55 | 2025-07-16 | Warnings | M013 362O9ITL9D |
| Pain Relief | ACETAMINOPHEN | Demoulas Super Markets, Inc | 397f2b63-733e-5b44-e063-6394a90a9718 | 2025-07-16 | Warnings | M013 313782 362O9ITL9D |
| DG HEALTH COLD FLU RELIEF | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Dolgencorp Inc | 8ea03891-2fbc-4413-8e6d-de903d426f8d | 2025-07-16 | Warnings | 362O9ITL9D |
| EXTRA STRENGTH PAIN RELIEF | ACETAMINOPHEN, ASPIRIN, CAFFEINE | BETTER LIVING BRANDS, LLC | eb6026d5-d88a-f6b3-e053-2a95a90a5b20 | 2025-07-15 | Warnings | M013 362O9ITL9D |
| Pain Relief PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Safeway | f9597abc-3f01-4b94-8078-228e0b74677e | 2025-07-15 | Warnings | M013 362O9ITL9D |
| up and up nighttime flu and severe cold and cough | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Target Corporation | df488727-b913-440b-9a0b-cce3ae143bf2 | 2025-07-15 | Warnings | 362O9ITL9D |
| Topcare DayTime Cold and Flu Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | Topco Associates LLC | bb9663e3-fd11-4e72-bf85-fee4841b795f | 2025-07-15 | Warnings | 362O9ITL9D |
| Berkley and Jensen Pain Relief | ACETAMINOPHEN | BJWC | d3ee3341-93b8-487c-921e-2892d213efbb | 2025-07-15 | Warnings | M013 362O9ITL9D |
| DG HEALTH COLD FLU RELIEF | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | Dolgencorp Inc | 320e4f32-66aa-48be-9afd-fa2b2c217dc1 | 2025-07-14 | Warnings | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Upsher-Smith Laboratories, LLC | 3aa0b733-b58f-46bd-8e76-37ddf1dc3356 | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| EXTRA PAIN RELIEF | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | TIME CAP LABS | 59482917-f80b-4bed-9218-068b35366eb3 | 2025-07-11 | Warnings | M013 362O9ITL9D |
| CVS PHARMACY MS Adult Severe Multi Symptom Cough Cold Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | CVS PHARMACY | cdc9af7c-3766-4573-9d95-bf217907b932 | 2025-07-11 | Warnings | 362O9ITL9D |
| HEADACHE RELIEF | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Kroger Company | bbed29a1-3c52-3531-e053-2995a90a686c | 2025-07-10 | Warnings | 362O9ITL9D |
| Nighttime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | CVS PHARMACY, INC | b765c82e-5021-4772-8647-c5ebc596bc0a | 2025-07-10 | Warnings | 362O9ITL9D |
| Up and Up Childrens acetaminophen | ACETAMINOPHEN | Target Corporation | 25a476a4-9969-49b3-94bf-b076bada4cea | 2025-07-10 | Warnings | M013 362O9ITL9D |
| Sinus Pressure and Pain | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Walgreen Company | c378acaf-389a-4afb-a4f0-e367a907a468 | 2025-07-10 | Warnings | 362O9ITL9D |
| Tylenol Extra Strength Caplet | ACETAMINOPHEN | Jones Healthcare Group - Packaging Services, Inc | fba711c1-4e69-49b0-8994-97c455aebcb2 | 2025-07-09 | Warnings | M013 362O9ITL9D |
| ACTIDOGESIC DF | ACETAMINOPHEN, DEXBROMPHENIRAMINE MALEATE | ACTIPHARMA, LLC | ff8e2565-bce3-4c06-a416-6e8f369f057f | 2025-07-09 | Warnings | 362O9ITL9D |
| Daytime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | P & L Development, LLC | 0bb006f6-c360-4cd5-81e9-0776d99d79e8 | 2025-07-08 | Warnings | 362O9ITL9D |
| good sense pain relief | ACETAMINOPHEN | L. Perrigo Company | af7ae548-38ad-41d5-b1cb-761cd2e386d3 | 2025-07-08 | Warnings | M013 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.